Provectus Biopharmaceuticals Inc (PVCT)
0.1964
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Provectus Biopharmaceuticals EPS Diluted (TTM): -0.0058 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0058 |
| September 30, 2023 | -0.0058 |
| June 30, 2023 | -0.0057 |
| March 31, 2023 | -0.0062 |
| December 31, 2022 | -0.0067 |
| September 30, 2022 | -0.0067 |
| June 30, 2022 | -0.0076 |
| March 31, 2022 | -0.0089 |
| December 31, 2021 | -0.0106 |
| September 30, 2021 | -0.0206 |
| June 30, 2021 | -0.022 |
| March 31, 2021 | -0.0223 |
| December 31, 2020 | -0.0228 |
| September 30, 2020 | -0.0228 |
| June 30, 2020 | -0.0235 |
| March 31, 2020 | -0.0294 |
| December 31, 2019 | -0.0283 |
| September 30, 2019 | -0.0183 |
| June 30, 2019 | -0.0178 |
| March 31, 2019 | -0.0116 |
| December 31, 2018 | -0.018 |
| September 30, 2018 | -0.028 |
| June 30, 2018 | -0.0338 |
| March 31, 2018 | -0.04 |
| December 31, 2017 | -0.04 |
| Date | Value |
|---|---|
| September 30, 2017 | -0.05 |
| June 30, 2017 | -0.08 |
| March 31, 2017 | -0.09 |
| December 31, 2016 | -0.12 |
| September 30, 2016 | -0.15 |
| June 30, 2016 | -0.14 |
| March 31, 2016 | -0.14 |
| December 31, 2015 | -0.12 |
| September 30, 2015 | -0.07 |
| June 30, 2015 | -0.06 |
| March 31, 2015 | -0.0437 |
| December 31, 2014 | -0.0637 |
| September 30, 2014 | -0.1837 |
| June 30, 2014 | -0.1937 |
| March 31, 2014 | -0.21 |
| December 31, 2013 | -0.21 |
| September 30, 2013 | -0.10 |
| June 30, 2013 | -0.09 |
| March 31, 2013 | -0.10 |
| December 31, 2012 | -0.10 |
| September 30, 2012 | -0.12 |
| June 30, 2012 | -0.16 |
| March 31, 2012 | -0.17 |
| December 31, 2011 | -0.18 |
| September 30, 2011 | -0.20 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-0.0294
Minimum
Mar 2020
-0.0057
Maximum
Jun 2023
-0.0154
Average
-0.0178
Median
Jun 2019
EPS Diluted (TTM) Benchmarks
| Insmed Inc | -5.34 |
| NeuroMetrix Inc | -5.882 |
| Intra-Cellular Therapies Inc | -1.46 |
| Rhythm Pharmaceuticals Inc | -3.20 |
| Amylyx Pharmaceuticals Inc | 0.70 |